Microbot Medical Inc. (MBOT) vs Nephros Inc. (NEPH)
- Microbot Medical Inc. MBOT 0.95 0.00%
- Nephros Inc. NEPH 3.65 +3.99%
Microbot Medical Inc. and Nephros Inc. are both Medical Instruments & Supplies companies. Microbot Medical Inc. is the larger, with a market value of $63.8M against $38.1M — 1.7× the size. Microbot Medical Inc. has negative trailing earnings, so its P/E is not meaningful; Nephros Inc. trades at 23.4×. Nephros Inc. grew revenue faster over the last twelve months: 24.2% against −59.1%. Nephros Inc. has the higher net margin (8.38% vs −3,955.2%) and the higher return on invested capital (14.1% vs −850.5%). Across the 18 metrics below, Nephros Inc. leads on 14 and Microbot Medical Inc. on 4.
Valuation
Profitability
| Metric | MBOT | NEPH | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | (166.30%) | 61.26% | 54.29% |
| Operating margin | (4,480.03%) | 7.92% | 1.07% |
| Net margin | (3,955.22%) | 8.38% | (1.61%) |
| Free cash flow margin | (4,340.11%) | (3.19%) | 1.08% |
| Return on equity | (32.91%) | 16.10% | (1.32%) |
| Return on assets | (30.68%) | 12.39% | 0.00% |
| Return on invested capital | (850.51%) | 14.11% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack